May 19, 2016
December 2015, Vol. 4, No. 6
Sample Size Calculation for Single-Arm Phase 2 Prostate Cancer Trials
Prostate cancer remains one of the major health issues for men worldwide and is the second leading cause of cancer-related death in males in the United States…
Related Articles
2015 Breast Cancer Symposium - December 28, 2015
FDA Drug Approvals: Earlier Availability for Promising Drugs
It’s no secret that developing cancer drugs is a time-consuming and costly endeavor. Although the FDA review represents only a fraction of the entire time line, accelerated evaluation can still shave years off this process. According to data presented at the 2015 Breast Cancer Symposium, expedited programs allow for intensive [ Read More ]
FDA Approvals, News & Updates - December 28, 2015
FDA Approves Opdivo to Treat Advanced Form of Kidney Cancer
On November 23, 2015, the FDA approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy. “Opdivo provides an important therapy option for patients with renal cell carcinoma,” said Richard Pazdur, MD, Director of [ Read More ]